Repair & Regeneration
Evidence-based Pru Health guides on repair & regeneration: peptide therapy, the research behind it, and the standards that govern compounded medicine.
Evidence-based Pru Health guides on repair & regeneration: peptide therapy, the research behind it, and the standards that govern compounded medicine.
A clear look at cibinetide, the EPO-derived peptide studied for nerve repair and small fiber neuropathy.
A clear look at what BPC-157 is studied for, how it's thought to work, and where the evidence stands.
The amounts studies used, how dose scales with body weight, and why any real dose should be set by a physician.
Capsules or a small daily shot. Here's how the two forms of BPC-157 really differ, in plain language.
The reported reactions, the open questions, and the one risk that matters most before you ever open a vial.
Two of the most searched recovery peptides, side by side: how each is thought to work, why people stack them, and what the 2026 FDA review means for access.
A complete look at the science, the two main forms, and how a prescribed, at-cost option differs from a drugstore serum or a research-grade vial.
What GHK-Cu can do for skin, how to read a before and after, and what the research shows.
A complete look at GHK-Cu dosing for the topical cream and the injectable form, what the science supports, and how pru dispenses its GHK-Cu as a prescribed, 503A-compounded cream at cost.
The copper peptide behind the scalp-serum trend, explained plainly: the studied mechanism, the real evidence, and how to use it.
What GHK-Cu is, what the research supports, its two forms, and how pru dispenses it as a prescribed, pharmacy-grade cream at cost.
A copper-binding peptide that your body already makes, in two forms, and what the science actually studies it for.
GHK-Cu serum is the topical, skin-first copper peptide. Here's how it works, what the research shows, how it compares to injection, and which one you can get today.
Per-vial, full-course, and clinic pricing, plus the sourcing question that matters more than the price.
A short peptide from alpha-MSH that research links to calmer gut and skin inflammation, explained simply.
A short fragment of alpha-MSH that researchers study for calming inflammation in the gut and skin, plus where it stands after the July 2026 FDA review.
One calms inflammation. One rebuilds tissue. Here's which fits your gut, your injury, and your recovery.
BPC-157, KPV and where gut-repair peptides really stand, plus the safe way to get them.
A clear, current look at the peptide people ask about for recovery, soft-tissue repair, and flexibility.
What the reported protocols say, what the science actually supports, and why the source of your peptide matters more than the number on the vial.
What people actually report, what's only theoretical, and why where you get it matters more than the peptide itself.
A clear roundup of the peptides studied for tissue repair, what the evidence really shows, and how to get them the right way.
BPC-157, TB-500, and GHK-Cu, what each is studied for, how strong the evidence really is, and how to get them the safe way.
How the two most-searched repair peptides fit together, what the science actually says, and where the FDA stands in 2026.
What it is, how it's thought to work, what it's studied for, and where access stands after the July 2026 FDA review.
What this natural recovery peptide is, how it differs from TB-500, and where it stands with the FDA this year.
The thymosin beta-4 fragment studied for recovery, how it works, and where it stands with the FDA.
What's for sale today, what's actually legal, and the safer path that may open after the FDA's July 2026 review.
The real state of the market, the legal picture, and the safer path for recovery.